Lataa...
Datasets of a novel bivalent single chain antibody constructed by overlapping oligonucleotide annealing method targeting human CD123
Current therapies for acute myeloid leukemia (AML), are associated with high relapse rates. Hence, development of new therapeutic strategies is crucial to circumvent this problem. Bivalent antibody technology has been used to engineer novel antibody fragments with increased avidity, by assembling tw...
Tallennettuna:
| Julkaisussa: | Data Brief |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976644/ https://ncbi.nlm.nih.gov/pubmed/27536714 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dib.2016.07.014 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|